 | • レポートコード：MRC23Q36737 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の血漿分画市場について調査・分析し、世界の血漿分画市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（免疫グロブリン、凝固因子、アルブミン、その他）、用途別セグメント分析（病院、薬局、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologicsなどが含まれています。世界の血漿分画市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、血漿分画市場規模を推定する際に考慮しました。本レポートは、血漿分画の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、血漿分画に関するビジネス上の意思決定に役立てることを目的としています。 ・血漿分画市場の概要 - 製品の定義 - 血漿分画のタイプ別セグメント - 世界の血漿分画市場規模：タイプ別分析（免疫グロブリン、凝固因子、アルブミン、その他） - 血漿分画の用途別セグメント - 世界の血漿分画市場規模：用途別分析（病院、薬局、その他） - 世界の血漿分画市場規模予測（2018年-2029年） - 血漿分画の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 血漿分画市場の競争状況およびトレンド ・血漿分画の地域別市場規模 - 北米の血漿分画市場規模（2018年-2029年） - アメリカの血漿分画市場規模（2018年-2029年） - ヨーロッパの血漿分画市場規模（2018年-2029年） - アジア太平洋の血漿分画市場規模（2018年-2029年） - 中国の血漿分画市場規模（2018年-2029年） - 日本の血漿分画市場規模（2018年-2029年） - 韓国の血漿分画市場規模（2018年-2029年） - インドの血漿分画市場規模（2018年-2029年） - オーストラリアの血漿分画市場規模（2018年-2029年） - 中南米の血漿分画市場規模（2018年-2029年） - 中東・アフリカの血漿分画市場規模（2018年-2029年） ・タイプ別セグメント：免疫グロブリン、凝固因子、アルブミン、その他 - 世界の血漿分画のタイプ別販売量（2018年-2023年） - 世界の血漿分画のタイプ別売上（2018年-2023年） - 世界の血漿分画のタイプ別価格 ・用途別セグメント：病院、薬局、その他 - 世界の血漿分画の用途別販売量（2018年-2023年） - 世界の血漿分画の用途別売上（2018年-2023年） - 世界の血漿分画の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics ・産業チェーンと販売チャネルの分析 - 血漿分画産業チェーン分析 - 血漿分画の主要原材料 - 血漿分画の販売チャネル - 血漿分画のディストリビューター - 血漿分画の主要顧客 ・血漿分画市場ダイナミクス - 血漿分画の業界動向 - 血漿分画市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Human blood plasma is nature’s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
Highlights
The global Blood Plasma Fractionation market was valued at US$ 28320 million in 2022 and is anticipated to reach US$ 47160 million by 2029, witnessing a CAGR of 7.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.
In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation.
The Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Fractionation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Segment by Application
Hospital
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Blood Plasma Fractionation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Blood Plasma Fractionation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Blood Plasma Fractionation Market Overview
1.1 Product Overview and Scope of Blood Plasma Fractionation
1.2 Blood Plasma Fractionation Segment by Type
1.2.1 Global Blood Plasma Fractionation Market Value Comparison by Type (2023-2029)
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Blood Plasma Fractionation Segment by Application
1.3.1 Global Blood Plasma Fractionation Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Blood Plasma Fractionation Market Size Estimates and Forecasts
1.4.1 Global Blood Plasma Fractionation Revenue 2018-2029
1.4.2 Global Blood Plasma Fractionation Sales 2018-2029
1.4.3 Global Blood Plasma Fractionation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Blood Plasma Fractionation Market Competition by Manufacturers
2.1 Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Blood Plasma Fractionation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Blood Plasma Fractionation Average Price by Manufacturers (2018-2023)
2.4 Global Blood Plasma Fractionation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Plasma Fractionation, Product Type & Application
2.7 Blood Plasma Fractionation Market Competitive Situation and Trends
2.7.1 Blood Plasma Fractionation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blood Plasma Fractionation Players Market Share by Revenue
2.7.3 Global Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Plasma Fractionation Retrospective Market Scenario by Region
3.1 Global Blood Plasma Fractionation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Blood Plasma Fractionation Global Blood Plasma Fractionation Sales by Region: 2018-2029
3.2.1 Global Blood Plasma Fractionation Sales by Region: 2018-2023
3.2.2 Global Blood Plasma Fractionation Sales by Region: 2024-2029
3.3 Global Blood Plasma Fractionation Global Blood Plasma Fractionation Revenue by Region: 2018-2029
3.3.1 Global Blood Plasma Fractionation Revenue by Region: 2018-2023
3.3.2 Global Blood Plasma Fractionation Revenue by Region: 2024-2029
3.4 North America Blood Plasma Fractionation Market Facts & Figures by Country
3.4.1 North America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Blood Plasma Fractionation Sales by Country (2018-2029)
3.4.3 North America Blood Plasma Fractionation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Plasma Fractionation Market Facts & Figures by Country
3.5.1 Europe Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Blood Plasma Fractionation Sales by Country (2018-2029)
3.5.3 Europe Blood Plasma Fractionation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Country
3.6.1 Asia Pacific Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Blood Plasma Fractionation Sales by Country (2018-2029)
3.6.3 Asia Pacific Blood Plasma Fractionation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blood Plasma Fractionation Market Facts & Figures by Country
3.7.1 Latin America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Blood Plasma Fractionation Sales by Country (2018-2029)
3.7.3 Latin America Blood Plasma Fractionation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Blood Plasma Fractionation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Plasma Fractionation Sales by Type (2018-2029)
4.1.1 Global Blood Plasma Fractionation Sales by Type (2018-2023)
4.1.2 Global Blood Plasma Fractionation Sales by Type (2024-2029)
4.1.3 Global Blood Plasma Fractionation Sales Market Share by Type (2018-2029)
4.2 Global Blood Plasma Fractionation Revenue by Type (2018-2029)
4.2.1 Global Blood Plasma Fractionation Revenue by Type (2018-2023)
4.2.2 Global Blood Plasma Fractionation Revenue by Type (2024-2029)
4.2.3 Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2029)
4.3 Global Blood Plasma Fractionation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Blood Plasma Fractionation Sales by Application (2018-2029)
5.1.1 Global Blood Plasma Fractionation Sales by Application (2018-2023)
5.1.2 Global Blood Plasma Fractionation Sales by Application (2024-2029)
5.1.3 Global Blood Plasma Fractionation Sales Market Share by Application (2018-2029)
5.2 Global Blood Plasma Fractionation Revenue by Application (2018-2029)
5.2.1 Global Blood Plasma Fractionation Revenue by Application (2018-2023)
5.2.2 Global Blood Plasma Fractionation Revenue by Application (2024-2029)
5.2.3 Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2029)
5.3 Global Blood Plasma Fractionation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Blood Plasma Fractionation Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Blood Plasma Fractionation Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols Blood Plasma Fractionation Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biotest Blood Plasma Fractionation Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BPL Blood Plasma Fractionation Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.9.4 RAAS Blood Plasma Fractionation Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CBPO Blood Plasma Fractionation Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Blood Plasma Fractionation Description and Business Overview
6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Tiantan Bio
6.12.1 Tiantan Bio Corporation Information
6.12.2 Tiantan Bio Blood Plasma Fractionation Description and Business Overview
6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
6.12.5 Tiantan Bio Recent Developments/Updates
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Corporation Information
6.13.2 Shuanglin Bio Blood Plasma Fractionation Description and Business Overview
6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
6.13.5 Shuanglin Bio Recent Developments/Updates
6.14 Boya Bio
6.14.1 Boya Bio Corporation Information
6.14.2 Boya Bio Blood Plasma Fractionation Description and Business Overview
6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
6.14.5 Boya Bio Recent Developments/Updates
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Corporation Information
6.15.2 Yuanda Shuyang Blood Plasma Fractionation Description and Business Overview
6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments/Updates
6.16 Weiguang Bio
6.16.1 Weiguang Bio Corporation Information
6.16.2 Weiguang Bio Blood Plasma Fractionation Description and Business Overview
6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
6.16.5 Weiguang Bio Recent Developments/Updates
6.17 Nanyue Bio
6.17.1 Nanyue Bio Corporation Information
6.17.2 Nanyue Bio Blood Plasma Fractionation Description and Business Overview
6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
6.17.5 Nanyue Bio Recent Developments/Updates
6.18 KM Biologics
6.18.1 KM Biologics Corporation Information
6.18.2 KM Biologics Blood Plasma Fractionation Description and Business Overview
6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
6.18.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Plasma Fractionation Industry Chain Analysis
7.2 Blood Plasma Fractionation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Plasma Fractionation Production Mode & Process
7.4 Blood Plasma Fractionation Sales and Marketing
7.4.1 Blood Plasma Fractionation Sales Channels
7.4.2 Blood Plasma Fractionation Distributors
7.5 Blood Plasma Fractionation Customers
8 Blood Plasma Fractionation Market Dynamics
8.1 Blood Plasma Fractionation Industry Trends
8.2 Blood Plasma Fractionation Market Drivers
8.3 Blood Plasma Fractionation Market Challenges
8.4 Blood Plasma Fractionation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer